EFA Technologies, pioneers in portable blood labs, today announces the start of its operations in Brazil, following approval last October of its leading portable blood lab device, RevDx, by Anvisa, the Brazilian health regulatory authority. The company also secured US$6.5 million in funding, boosting EFA’s mission to further improve healthcare worldwide. Read full press release here.
One Comment